Trial Profile
Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving biphasic insulin aspart 30 or biphasic human insulin 30
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Mar 2011 New trial record